LifeStance Health Group Reports Strong Q3 2024 Growth

Lifestance Health Group, Inc. ( (LFST) ) has released its Q3 earnings. Here is a breakdown of the information Lifestance Health Group, Inc. presented to its investors.

LifeStance Health Group, Inc., one of the largest providers of outpatient mental healthcare in the United States, offers virtual and in-person services for a wide range of mental health conditions across 33 states through more than 550 centers.

The company’s third-quarter results for 2024 reflect significant improvements, with a 19% increase in revenue to $312.7 million, a notable reduction in net loss to $6.0 million from $61.6 million, and a 110% rise in Adjusted EBITDA to $30.7 million.

Key drivers for this growth include a 13% increase in the clinician base, enhancing visit volumes by 15% to 2 million. The Center Margin also saw a 32% uplift, reaching $100.4 million, reflecting better revenue per visit and operational efficiency. LifeStance has raised its full-year 2024 revenue expectations to between $1.228 billion and $1.248 billion, indicating strong business momentum.

Looking ahead, LifeStance remains optimistic about maintaining its growth trajectory, with raised guidance for revenue, Center Margin, and Adjusted EBITDA for the full year 2024. The company also expects to continue generating positive free cash flow, demonstrating resilience in the face of industry challenges.